- Report
- January 2024
North America
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
Middle East, Africa
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 747 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- June 2023
- 245 Pages
Global
From €3394EUR$3,570USD£2,851GBP
- Report
- December 2021
- 190 Pages
Global
From €3529EUR$3,712USD£2,965GBP
- Book
- February 2023
- 576 Pages
- Book
- December 2022
- 464 Pages
- Book
- December 2021
- 576 Pages
- Book
- February 2021
- 512 Pages
- Book
- July 2024
- 480 Pages
- Book
- July 2015
- 384 Pages
- Book
- March 2013
- 536 Pages
- Book
- January 2013
- 632 Pages

Nanocarriers are a type of drug delivery system that utilizes nanotechnology to transport drugs to targeted areas of the body. These nanocarriers are typically composed of polymeric materials, lipids, or inorganic materials, and are designed to protect the drug from degradation and to increase its bioavailability. Nanocarriers can also be used to target specific cells or tissues, allowing for more efficient drug delivery.
Nanocarriers are increasingly being used in the drug delivery market, as they offer a number of advantages over traditional drug delivery systems. These advantages include improved drug stability, increased bioavailability, and targeted delivery. Additionally, nanocarriers can be used to deliver a variety of drugs, including small molecules, proteins, and nucleic acids.
Some companies in the nanocarrier drug delivery market include NanoCarrier Co., Ltd., Nanoform Finland Oy, and NanoPass Technologies. Show Less Read more